HCP Clinical Challenge: Test Your Endometriosis Knowledge
Reviewed by: HU Medical Review Board | Last reviewed: December 2025 | Last updated: December 2025
Key Takeaways:
- Diagnosis of endometriosis in adolescents is often delayed because symptoms are frequently normalized.
- Identifying characteristics such as the length of a woman’s menstrual cycle can inform clinical assessments.
- Myfembree® is an FDA-approved, once-daily oral treatment indicated for the management of moderate to severe pain associated with endometriosis.
Test your endometriosis knowledge
Endometriosis is a complex, chronic condition that affects approximately 10 to 15 percent of reproductive-aged women. Despite its prevalence, patients often face significant delays in diagnosis and management.1
This quiz is designed to test your clinical acumen on the pathophysiology, diagnosis, and treatment of endometriosis. See how your knowledge compares to the latest evidence-based recommendations.
Quick Quiz
Which of the following menstrual history characteristics is a statistically significant risk factor for developing endometriosis?
Quick Quiz
According to recent guidelines, regarding the surgical management of ovarian endometriomas larger than 3 cm, which surgical technique is preferred and why?
Quick Quiz
Epidemiological studies indicate that endometriosis is associated with a modest increased risk of developing specific subtypes of ovarian cancer. Which histologic subtypes are most strongly linked to endometriosis?
Quick Quiz
Diagnosis in adolescents is often delayed due to symptom normalization. According to recent data, what is the estimated prevalence of endometriosis in adolescents with chronic pelvic pain or dysmenorrhea resistant to NSAIDs and hormonal treatment?
Quick Quiz
Which of the following statements regarding the use of relugolix combination therapy (Myfembree®) for endometriosis is correct based on FDA approval data?